Author: Coiffard, Benjamin; Prud’Homme, Eloi; Hraiech, Sami; Cassir, Nadim; Le Pavec, Jérôme; Kessler, Romain; Meloni, Federica; Leone, Marc; Thomas, Pascal Alexandre; Reynaud-Gaubert, Martine; Papazian, Laurent
Title: Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation Cord-id: o8cl2v3p Document date: 2020_4_29
ID: o8cl2v3p
Snippet: BACKGROUND: Infection is the most common cause of mortality within the first year after lung transplantation (LTx). The management of perioperative antibiotic therapy is a major issue, but little is known about worldwide practices. METHODS: We sent by email a survey dealing with 5 daily clinical vignettes concerning perioperative antibiotic therapy to 180 LTx centers around the world. The invitation and a weekly reminder were sent to lung transplant specialists for a single consensus answer per
Document: BACKGROUND: Infection is the most common cause of mortality within the first year after lung transplantation (LTx). The management of perioperative antibiotic therapy is a major issue, but little is known about worldwide practices. METHODS: We sent by email a survey dealing with 5 daily clinical vignettes concerning perioperative antibiotic therapy to 180 LTx centers around the world. The invitation and a weekly reminder were sent to lung transplant specialists for a single consensus answer per center during a 3-month period. RESULTS: We received a total of 99 responses from 24 countries, mostly from Western Europe (n = 46) and the USA (n = 34). Systematic screening for bronchial recipient colonization before LTx was mostly performed with sputum samples (72%), regardless of the underlying lung disease. In recipients without colonization, antibiotics with activity against gram-negative bacteria resistant strains (piperacillin / tazobactam, cefepime, ceftazidime, carbapenems) were reported in 72% of the centers, and antibiotics with activity against methicillin-resistant Staphylococcus aureus (mainly vancomycin) were reported in 38% of the centers. For these recipients, the duration of antibiotics reported was 7 days (33%) or less (26%) or stopped when cultures of donor and recipients were reported negatives (12%). In recipients with previous colonization, antibiotics were adapted to the susceptibility of the most resistant strain and given for at least 14 days (67%). CONCLUSION: Practices vary widely around the world, but resistant bacterial strains are mostly targeted even if no colonization occurs. The antibiotic duration reported was longer for colonized recipients.
Search related documents:
Co phrase search for related documents- absolute contraindication and long therapy: 1
- active mycobacterial infection and additional file: 1
- acute kidney injury and additional file: 1, 2, 3, 4, 5, 6
- acute kidney injury and administration route: 1
- acute kidney injury and local practice: 1, 2, 3
- acute kidney injury and local protocol: 1, 2, 3
- acute kidney injury and long duration: 1
- acute kidney injury and long therapy: 1, 2
- acute kidney injury risk and administration route: 1
- additional file and administration route: 1
- additional file and local practice: 1, 2, 3
- additional file and local protocol: 1, 2, 3, 4, 5, 6
- administration route and local practice: 1
Co phrase search for related documents, hyperlinks ordered by date